News
A techno-economic analysis has found that French cultivated meat startup Gourmey's bioreactor system can reach production ...
Bioreactor costs have been cut even more significantly, being reduced by 95%. According to Meatly, the company’s own 320L ...
The results indicate that beef, lamb, milk, and eggs are more vulnerable to market competition from cultivated alternatives ...
9h
Zacks.com on MSNIs Bio-Techne Stock the Right Pick for Your Portfolio Now?TECH is gaining ground in cell and gene therapy, and with Ella, while navigating macro hurdles. Is it the right fit for your portfolio today?
5d
Discover Magazine on MSNHow the Non-Essential Spleen Could Regenerate Vital Organs Inside the BodyScientists are repurposing this once non-essential organ to grow life-saving tissues on demand and from inside the body.
The cultivated meat major Gourmey has cut the costs of producing cultivated meat to €7/kg at commercial scale.
In Germany, a quarter of consumers are open to trying cultivated meat made from a 3D printer, a share much greater than it ...
3d
The Body Optimist on MSNThis is what your diet will look like in 10 years (animal protein is no longer king)What if your steak tonight was replaced in 10 years by a lentil burger or a cricket skewer? Don't panic: tomorrow's plate ...
Cultivated meat company Meatly has completed commissioning and its initial cell growth tests using a newly developed ...
The cell line development market is growing at a CAGR of approximately 8-10% due to the increasing adoption of cell-based ...
Scientists discovered the spleen can support insulin-producing cells from the pancreas. This may change diabetes care.
14h
News-Medical.Net on MSNTransforming Lab Workflows with Cell Culture Automation: Insights from Unicorn Biotechnologies at SLAS 2025Discover how Unicorn Biotechnologies is revolutionizing lab workflows with cell culture automation. Expert insights from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results